Gambro acquires clinics in the US

Gambro acquires clinics in the US Stockholm, Sweden, April 3, 2001 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that its wholly owned US subsidiary, Gambro Healthcare, Inc., has acquired substantially all of the dialysis- related assets owned by Renal Management, Inc. (RMI). These assets include 21 clinics that serve 950 patients in Louisiana, Nebraska, Iowa, Missouri and Kansas. Prior to this acquisition, RMI also held contracts to provide acute dialysis services to 16 hospitals and skilled nursing facilities whereby approximately 11,000 acute treatments are performed annually. "We are very excited about adding Renal Management Inc. into the Gambro Healthcare family. This acquisition further demonstrates Gambro's commitment to providing quality care for our patients and being among the world's leaders in the industry. Also, we are pleased that Jo Ann Otts, Vice President of Operations for RMI, will join the Gambro team as a Regional Vice President of Operations and continue to manage the operations and development of the acquired clinics. This acquisition gives Gambro a greater presence within Louisiana, Nebraska, Iowa, Missouri and Kansas," stated Larry Buckelew, President and CEO of Gambro Healthcare US. "Focus for Gambro Healthcare US in the immediate future remains on internal processes and leverage on the new organizational and management structure in order to improve both care and business quality. During this phase there will be fewer acquisitions than were implemented previously, and investments in new business opportunities will be made on highly selective criteria." Gambro now owns, operates, manages or provides consulting services to about 520 dialysis centers in the United States that serve over 39,000 patients across 33 states and the District of Columbia. Gambro Healthcare is a leading provider of kidney dialysis services in the US. It is a fully integrated service provider of renal replacement therapy. Its activities include physician practice management, dialysis services, and clinical laboratory services. For further information please contact: Bengt Modéer, Investor Relations, tel. +46-8-613 65 00, +46-733-66 65 33 Karin Avasalu, Corporate Communications, tel. +46-8-613 65 00, +46-70- 513 65 99 Kevin Smith, President Gambro Inc., Investor Relations US, tel. +1-303 231 4750 ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/04/03/20010403BIT00220/bit0001.doc http://www.bit.se/bitonline/2001/04/03/20010403BIT00220/bit0001.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe